These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23796320)

  • 1. Identification of a serine protease inhibitor which causes inclusion vacuole reduction and is lethal to Chlamydia trachomatis.
    Gloeckl S; Ong VA; Patel P; Tyndall JD; Timms P; Beagley KW; Allan JA; Armitage CW; Turnbull L; Whitchurch CB; Merdanovic M; Ehrmann M; Powers JC; Oleksyszyn J; Verdoes M; Bogyo M; Huston WM
    Mol Microbiol; 2013 Aug; 89(4):676-89. PubMed ID: 23796320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protease inhibitor JO146 demonstrates a critical role for CtHtrA for Chlamydia trachomatis reversion from penicillin persistence.
    Ong VA; Marsh JW; Lawrence A; Allan JA; Timms P; Huston WM
    Front Cell Infect Microbiol; 2013; 3():100. PubMed ID: 24392355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of recent Chlamydia trachomatis clinical isolates to the CtHtrA inhibitor JO146.
    Ong VA; Lawrence A; Timms P; Vodstrcil LA; Tabrizi SN; Beagley KW; Allan JA; Hocking JS; Huston WM
    Microbes Infect; 2015; 17(11-12):738-44. PubMed ID: 26369711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Chlamydia trachomatis strain with a chemically generated amino acid substitution (P370L) in the cthtrA gene shows reduced elementary body production.
    Marsh JW; Wee BA; Tyndall JD; Lott WB; Bastidas RJ; Caldwell HD; Valdivia RH; Kari L; Huston WM
    BMC Microbiol; 2015 Sep; 15():194. PubMed ID: 26424482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CtHtrA: the lynchpin of the chlamydial surface and a promising therapeutic target.
    Marsh JW; Ong VA; Lott WB; Timms P; Tyndall JD; Huston WM
    Future Microbiol; 2017 Jul; 12():817-829. PubMed ID: 28593794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel protease inhibitor causes inclusion vacuole reduction and disrupts the intracellular growth of Chlamydia trachomatis.
    Zhou Y; Lu X; Huang D; Lu Y; Zhang H; Zhang L; Yu P; Wang F; Wang Y
    Biochem Biophys Res Commun; 2019 Aug; 516(1):157-162. PubMed ID: 31202460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of a conserved role for Chlamydia HtrA in the replication phase of the chlamydial developmental cycle.
    Patel P; De Boer L; Timms P; Huston WM
    Microbes Infect; 2014 Aug; 16(8):690-4. PubMed ID: 25066238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of peptide-based inhibitors targeting the HtrA serine protease in Chlamydia: Design, synthesis and biological evaluation of pyridone-based and N-Capping group-modified analogues.
    Hwang J; Strange N; Phillips MJA; Krause AL; Heywood A; Gamble AB; Huston WM; Tyndall JDA
    Eur J Med Chem; 2021 Nov; 224():113692. PubMed ID: 34265463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidase Inhibitor 15 (PI15) Regulates Chlamydial CPAF Activity.
    Prusty BK; Chowdhury SR; Gulve N; Rudel T
    Front Cell Infect Microbiol; 2018; 8():183. PubMed ID: 29900129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad recruitment of mGBP family members to Chlamydia trachomatis inclusions.
    Lindenberg V; Mölleken K; Kravets E; Stallmann S; Hegemann JH; Degrandi D; Pfeffer K
    PLoS One; 2017; 12(9):e0185273. PubMed ID: 28945814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of Chlamydia trachomatis serovar L2 with the host autophagic pathway.
    Al-Younes HM; Brinkmann V; Meyer TF
    Infect Immun; 2004 Aug; 72(8):4751-62. PubMed ID: 15271937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of modulated gene expression in a model of Interferon-gamma-induced persistence of Chlamydia trachomatis in HEp-2 cells.
    Kokab A; Jennings R; Eley A; Pacey AA; Cross NA
    Microb Pathog; 2010 Nov; 49(5):217-25. PubMed ID: 20558272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipooligosaccharide is required for the generation of infectious elementary bodies in Chlamydia trachomatis.
    Nguyen BD; Cunningham D; Liang X; Chen X; Toone EJ; Raetz CR; Zhou P; Valdivia RH
    Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10284-9. PubMed ID: 21628561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HtrA, fatty acids, and membrane protein interplay in
    Strange N; Luu L; Ong V; Wee BA; Phillips MJA; McCaughey L; Steele JR; Barlow CK; Cranfield CG; Myers G; Mazraani R; Rock C; Timms P; Huston WM
    J Bacteriol; 2024 Apr; 206(4):e0037123. PubMed ID: 38445896
    [No Abstract]   [Full Text] [Related]  

  • 16. the active site residue V266 of Chlamydial HtrA is critical for substrate binding during both in vitro and in vivo conditions.
    Gloeckl S; Tyndall JD; Stansfield SH; Timms P; Huston WM
    J Mol Microbiol Biotechnol; 2012; 22(1):10-6. PubMed ID: 22353774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia protease-like activity factor (CPAF): characterization of proteolysis activity in vitro and development of a nanomolar affinity CPAF zymogen-derived inhibitor.
    Bednar MM; Jorgensen I; Valdivia RH; McCafferty DG
    Biochemistry; 2011 Sep; 50(35):7441-3. PubMed ID: 21830778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rab6 effector Bicaudal D1 associates with Chlamydia trachomatis inclusions in a biovar-specific manner.
    Moorhead AR; Rzomp KA; Scidmore MA
    Infect Immun; 2007 Feb; 75(2):781-91. PubMed ID: 17101644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis.
    Muschiol S; Bailey L; Gylfe A; Sundin C; Hultenby K; Bergström S; Elofsson M; Wolf-Watz H; Normark S; Henriques-Normark B
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14566-71. PubMed ID: 16973741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-thermal argon plasma is bactericidal for the intracellular bacterial pathogen Chlamydia trachomatis.
    Ermolaeva SA; Sysolyatina EV; Kolkova NI; Bortsov P; Tuhvatulin AI; Vasiliev MM; Mukhachev AY; Petrov OF; Tetsuji S; Naroditsky BS; Morfill GE; Fortov VE; Grigoriev AI; Zigangirova NA; Gintsburg AL
    J Med Microbiol; 2012 Jun; 61(Pt 6):793-799. PubMed ID: 22361459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.